NGM BIOPHARMACEUTICALS INC Operating Lease Liability
NGM BIOPHARMACEUTICALS INC had Operating Lease Liability of $1.38 million as of 2023-09-30, per its 10-Q filed 2023-11-02.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2023-11-02
- 2023-09-30: Operating Lease, Liability $1.38M.
- 2023-06-30: Operating Lease, Liability $2.75M.
- 2023-03-31: Operating Lease, Liability $4.07M.
- 2022-12-31: Operating Lease, Liability $5.38M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2023-09-30 | $1.38M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $2.75M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $4.07M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $5.38M 10-K · filed 2023-02-28 | |
| 2021-12-31 | $6.69M 10-Q · filed 2022-11-03 | $10.46M 10-K · filed 2022-03-01 |